Sleeboom-Faulkner, Margaret, Chen, Haidan and Rosemann, Achim (2018) Regulatory capacity building and the governance of clinical stem cell research in China. Science and Public Policy, 45 (3). pp. 416-427. ISSN 0302-3427

	PDF - Published Version Available under License Creative Commons Attribution. Download (214kB)
	PDF - Published Version Available under License Creative Commons Attribution. Download (203kB)
	PDF - Accepted Version Restricted to SRO admin only Download (298kB)

Abstract

While other works have explained difficulties in applying ‘international’ guidelines in the field of regenerative medicine in so-called low- and middle-income countries (LMICs) in terms of ‘international hegemony’, ‘political and ethical governance’ and ‘cosmopolitisation’, this article on stem cell regulation in China emphasises the particular complexities faced by large LMICs: the emergence of alternative regulatory arrangements made by stakeholders at a provincial level at home. On the basis of ethnographic and archival research of clinical stem cell research hubs, we have characterized six types of entrepreneurial ‘bionetworks’, each of which embodies a regulatory orientation that developed in interaction with China’s regulatory dilemmas. Rather than adopting guidelines from other countries, we argue that regulatory capacity building is more appropriately viewed as a relational concept, referring to the ability to develop regulatory requirements that can cater for different regulatory research needs on an international level and at home.

Item Type:	Article
Schools and Departments:	School of Global Studies > Anthropology
Depositing User:	Achim Rosemann
Date Deposited:	13 Nov 2017 09:44
Last Modified:	02 Jul 2019 15:17
URI:	http://sro.sussex.ac.uk/id/eprint/71143

View download statistics for this item

📧 Request an update